Genomictree Inc. (KOSDAQ:228760)
11,540
-420 (-3.51%)
Jul 21, 2026, 2:25 PM KST
Genomictree Market Cap
Genomictree has a market cap or net worth of 293.34 billion as of July 20, 2026. Its market cap has decreased by -7.91% in one year.
Market Cap
293.34B
Enterprise Value
218.31B
Revenue
3.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,540.00
ChartMarket Cap Chart
Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 293.34B, an increase of 397.19%. That is a compound annual growth rate of 18.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 293.34B | -55.52% |
| Dec 30, 2025 | 659.41B | 34.41% |
| Dec 30, 2024 | 490.60B | 0.78% |
| Dec 28, 2023 | 486.82B | 168.25% |
| Dec 29, 2022 | 181.48B | -32.87% |
| Dec 30, 2021 | 270.36B | -7.66% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GI Innovation | 472.26B |
| Medy-Tox | 466.66B |
| GC Corp. | 437.22B |
| MEDIPOST | 342.39B |
| SillaJen | 286.81B |
| Proteina | 265.95B |
| BINEX | 214.65B |
| EASY BIO,Inc. | 208.09B |